Site Search

Annual Reports

Investors & Media

2023 Annual Report

Archived Reports

2022 Annual Report

2022 Proxy Statement 2022 Annual Report

2021 Annual Report

2021 Proxy Statement 2021 Annual Report

2020 Annual Report

2020 Annual Report 2020 Proxy Statement

2019 Annual Report

2018 Annual Report

2017 Annual Report

2016 Annual Report

2015 Annual Report

2014 Annual Report

Contact Us

Sonya Weigle
Chief People and
Investor Relations Officer
Marinus Pharmaceuticals, Inc.

sweigle@marinuspharma.com

Molly Cameron
Director, Corporate Communications & Investor Relations
Marinus Pharmaceuticals, Inc.

investors@marinuspharma.com

Quick Links

SEC Filings
Investor FAQs

Investor Email Alerts

To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.

At Marinus Pharmaceuticals, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

By providing your email address below, you are providing consent to Marinus Pharmaceuticals to send you the requested Investor Email Alert updates.

* Required

Email Address *

Investor Alert Options *

News
Events & Presentations
Quarterly Reports
Annual Reports
SEC Filings
End of Day Stock Quote

Unsubscribe